Vol. 5 (11) pp. 1292-1299 DOI: 10.21474/IJAR01/5897

THERAPEUTIC EFFECT OF P- COUMARIC ACID AGAINST SULFASALAZINE- INDUCED PULMONARY TOXICITY IN ADULT MALE RATS.

  • Zoology Department, Women?s College For Arts, Science And Education ?Ain Shams University, Egypt.
11 Downloads 89 Views
Crossref

Abstract

Objective: p- Coumaric acid (p- CA) is an pervasive plant metabolite with antioxidant, anti- inflammatory and anticancer possessions. The present study was designed to estimate the curative effect of p- CA on sulfasalazine stimulated pulmonary injury. Materials and Methods: 20 adult male albino rats were divided into 4 groups; group (1): control group received 0.5ml carboxy methyl cellulose (CMC), group (2): rats were treated with p- CA (100 mg/ kg b.w.), group (3): animals were treated with sulfasalazine (600 mg/ kg b.w.), (4): rats were treated with sulfasalazine associated with p-CA. The injection of both substances was orally for 2 weeks. At the end of the treatment, the rats were sacrificed and lungs were taken out for biochemical, histological, histochemical and immnuohistochemical examinations. Results: Sulfasalazine caused pulmonary injury as judged by an increase in MDA tissue level and decrease in SOD and GSH levels. The thickness of alveolar epithelium and hemorrhage were observed. There was an increment in collagen fibers around bronchiole and in the lung interstitium. Moreover, positive alpha smooth muscle actin (α- SMA)- immunoreactivity detected within the cytoplasm of fibroblast cells. Administration of p- CA restorative these changes towards normal state. Conclusion: The handling with p- CA could serve as a potential protective agent with therapeutic capabilities against sulfasalazine induced- lung toxicity.

Keywords

Article Analytics

References

  1. Abdel-Gawad, FA.,et al. (2014): Lung damage after long-term exposure of adult rats to sodium fluoride. Arch Med Sci., 10(5):1035-1040.
  2. Abdel- Wahab, MH., et al. (2003): Influence of p- Coumaric acid on doxorubicin- induced oxidative stress in rat?s heart. Pharmacol. Res., 48: 461- 465.
  3. Bancroft, JD. and Cook, HC. (1994): Immunohistochemistry. In: Bancroft, JD. and Cook, HC.: Manual of Histological Techniques and their Diagnostic Applications. 2nd London, Madrid, Melbourne, New York, Tokyo: Churchill Livingstone, Edinburgh, 263- 325.
  4. Bancroft, JD. and Gamble, M. (2002): Theory and Practice of Histological Techniques. 5th, Churchill Livingstone, London, 167- 170.
  5. Barros, MP., et al. (2008): Evaluation of antiulcer activity of the main phenolic acids found in Brazilian Green Propolis. J. Ethnopharmacol., 120 (3): 372- 377.
  6. Beutler, E., et al. (1963): Colorimetric method for determination of glutathione reduced. J. Lab Clin. Med., 61: 882.
  7. Bhullar, S., et al. (2007): Severe nitrofurantoin lung disease resolving without the use of steroids. J. Postgrad. Med., 53: 111- 113.
  8. Corea, N. (2007): Sulfasalazine. In: Enna, SJ.; Bylund, DB., eds. x Pharm: The Comprehensive Pharmacology Ref. New York: Elsevier: 1- 5.
  9. Dawson, B. and Trapp, RG. (2001):. Basic and Clinical Biostatistics. 3rd New York, NY: Lang Medical Books/ McGraw- Hill.
  10. Durmuş-Altun,G., et al. (2005): Use of iodine-123 metaiodobenzylguanidine scintigraphy for the detection of amiodarone induced pulmonary toxicity in a rabbit model: A comparative study with technetium-99m diethyltriaminepenta acetic acid radioaerosol scintigraphy, Ann. Nucl. Med., 19: 217- 224.
  11. Harris, H.F. (1900): After Bruce Casselman W.C. (1959): Histochemical Technique, by Methuen and Co. LTd.
  12. Heidari, R., et al. (2016): Sulfasalazine- induced renal and hepatic injury in rats and the protective role of taurine. Biolmpacts, 6 (1):3- 8.
  13. Kong, CS., et al. (2013): Antiangiogenic effects of p- Coumaric acid in human endothelial cells. Phytother. Res., 27: 317- 323.
  14. Koulaouzidis, A., et al. (2007): Nitrofurantoin-induced lung- and hepatotoxicity. Hepatol., 6(2):119-21.
  15. Kulkarni, AA., et al. (2013): The triterpenoid CDDO-Me inhibits bleomycin-induced lung inflammation and fibrosis. PLoS One.,?8(5):e63798.
  16. Kumar, M., et al.(2004): Cellular and interactions in pulmonary fibrosis. Robbins and Cotran: Pathological Basis of Disease, 7th Library of Congress, Philadelphia, 27- 118.
  17. Lee, SJ., et al. (2009): Evidence for the association of peroxidases with the antioxidant effect of p- Coumaric acid in endothelial cells exposed to high glucose plus arachidonic acid. BMB Reports, 42: 561- 567.
  18. Linares, V., et al.(2009): Lipid peroxidation and antioxidant status in kidney and liver of rats treated with sulfasalazine. Toxicol., 256:152- 156.
  19. Linares, V., et al.(2011): Oxidative stress as a mechanism underlying sulfasalazine- induced toxicity. Expert Opioion on Drug Safety, 10: 253- 263.
  20. Linnebur, SA. andParnes, BL. (2004): Pulmonary and hepatic toxicity due to nitrofurantoin and fluconazole treatment. Ann Pharmacother.,38(4):612-616.
  21. Massey, TE., et al. (1995): Mechanisms in the pathogenesis of amiodarone-induced pulmonary toxicity. J. Physiol. Pharmacol.,73(12):1675-1685.
  22. Nishikimi, M., et al. (1972): The occurrence of superoxide anion in the reaction of reduced phenazine methosulphate and molecular oxygen. Biochem.Biophys. Res. Comm., 46(2), 849-854.
  23. Ohkawa, H., et al. (1979): Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Annals of Biochemistry, 95, 351- 358.
  24. Sabry, MM., et al. (2014): Histolgical and immunohistochemical study on the effect of stem cell therapy on bleomycin induced pulmonary fibrosis in albino rat. J Stem Cells.,7(1):33-42.
  25. Schwaiblmair, M., et al. (2012): Drug induced interstitial lung disease. The Open Respiratory Medicine J., 6: 63- 74.
  26. Serrano-Mollar, A., et al. (2003): In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats. Br J Pharmacol.,138(6):1037-1048.
  27. Shairibha, R.S.M. and Rajadurai, M. (2014): Anti-diabetic effect of p-coumaric acid on lipid peroxidation, antioxidant status and histopathological examinations in streptozotocin-induced diabetic rats. Int. J. Int sci. Inn. Tech. Sec. B, 3:01-11.
  28. Stankiewicz, A., et al. (2002): Effect of amifostine on lung oxidative stress after cyclophosphamide therapy. Bull. Vet. Inst. Pulawy., 46, 87-94.
  29. Vauzour, D., et al. (2010): Caffeic acid, tyrosol and p- Coumaric acid are potent inhibitors of 5- S- Cysteinyl- dopamine induced neurotoxicity. Arch. Biochem. Biophys., 501: 106- 111.
  30. Walsh, DA. and Pearson, CI. (2001): Angiogenesis in the pathogenesis of inflammatory joint and lung disease. Arthritis Res., 3 (3): 147- 153.
  31. Yoon, SA., et al. (2013): p- Coumaric acid modulates glucose and lipid metabolism via AMP- activated protein kinase in L6 skeletal muscle cells. Biochem. And Bioohys. Res. Commun., 432: 553- 557.
  32. Zidan, RA. (2010): Effect of long-term administration of amiodarone on rat lung and the possible protective role of vitamin E: A histological and immunohistochemical study. Egypt. J. Histol., 34: 117- 128.

How to Cite This Article

Aml Salem Saleh Ahmed. (2017); THERAPEUTIC EFFECT OF P- COUMARIC ACID AGAINST SULFASALAZINE- INDUCED PULMONARY TOXICITY IN ADULT MALE RATS., Int. J. of Adv. Res., 5 (11), 1292-1299, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/5897

Corresponding Author

Aml Salem Saleh Ahmed
zoology department, Women's college for Arts, Science& Education, Ain Shams University, Egypt